145 related articles for article (PubMed ID: 6249621)
1. Effects of chronic administration of delta 9-tetrahydrocannabinol on the cardiovascular system, and pressor and behavioral responses to brain stimulation in freely moving rats.
Kawasaki H; Watanabe S; Ueki S
Eur J Pharmacol; 1980 Jul; 65(1):63-9. PubMed ID: 6249621
[TBL] [Abstract][Full Text] [Related]
2. Effects of delta-9-tetrahydrocannabinol on the cardiovascular system, and pressor and behavioral responses to brain stimulation in rats.
Kawasaki H; Watanabe S; Oishi R; Ueki S
Jpn J Pharmacol; 1980 Aug; 30(4):493-502. PubMed ID: 6259394
[TBL] [Abstract][Full Text] [Related]
3. Effects of psychotropic drugs on pressor and behavioral responses to brain stimulation in unrestrained, unanesthetized rats.
Kawasaki H; Watanabe S; Ueki S
Pharmacol Biochem Behav; 1979 Jun; 10(6):907-15. PubMed ID: 482312
[TBL] [Abstract][Full Text] [Related]
4. Tolerance to the effects of delta 1-tetrahydrocannabinol on the pressor responses to noradrenaline in rats.
Li DM
Clin Exp Pharmacol Physiol; 1981; 8(2):101-8. PubMed ID: 6265124
[TBL] [Abstract][Full Text] [Related]
5. Tolerance to the cardiovascular effects of delta9-tetrahydrocannabinol in the rat.
Adams MD; Chait LD; Earnhardt JT
Br J Pharmacol; 1976 Jan; 56(1):43-8. PubMed ID: 1252665
[TBL] [Abstract][Full Text] [Related]
6. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
Oviedo A; Glowa J; Herkenham M
Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of delta 9- and delta 9(11)-tetrahydrocannabinol and their interaction with epinephrine.
Estrada U; Brase DA; Martin BR; Dewey WL
Life Sci; 1987 Jul; 41(1):79-87. PubMed ID: 3037218
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of pressor and behavioral responses to brain stimulation following bilateral olfactory bulbectomy in freely moving rats.
Kawasaki H; Watanabe S; Ueki S
Brain Res Bull; 1980; 5(6):711. PubMed ID: 7193505
[TBL] [Abstract][Full Text] [Related]
9. The effects of adrenalectomy on the cardiovascular responses to delta 1-tetrahydrocannabinol in rats.
Li DM; Chung JP
Clin Exp Pharmacol Physiol; 1978; 5(3):207-13. PubMed ID: 668209
[TBL] [Abstract][Full Text] [Related]
10. The in vitro and in vivo cardiovascular effects of Delta9-tetrahydrocannabinol in rats made hypertensive by chronic inhibition of nitric-oxide synthase.
O'Sullivan SE; Randall MD; Gardiner SM
J Pharmacol Exp Ther; 2007 May; 321(2):663-72. PubMed ID: 17284670
[TBL] [Abstract][Full Text] [Related]
11. Time-course of the effects of chronic delta 9-tetrahydrocannabinol on behaviour, body temperature, brain amines and withdrawal-like behaviour in the rat.
Taylor DA; Fennessy MR
J Pharm Pharmacol; 1982 Apr; 34(4):240-5. PubMed ID: 6124598
[TBL] [Abstract][Full Text] [Related]
12. Alteration in the level of endogenous hypothalamic prostaglandins induced by delta 9-tetrahydrocannabinol in the rat.
Coupar IM; Taylor DA
Br J Pharmacol; 1982 May; 76(1):115-9. PubMed ID: 6282371
[TBL] [Abstract][Full Text] [Related]
13. Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity.
Katsidoni V; Kastellakis A; Panagis G
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2273-84. PubMed ID: 23830148
[TBL] [Abstract][Full Text] [Related]
14. Effects of Delta 9-tetrahydrocannabinol, (R)-methanandamide, SR 141716,and d-amphetamine before and during daily Delta 9-tetrahydrocannabinol dosing.
Lamb RJ; Järbe TU; Makriyannis A; Lin S; Goutopoulos A
Eur J Pharmacol; 2000 Jun; 398(2):251-8. PubMed ID: 10854837
[TBL] [Abstract][Full Text] [Related]
15. Marihuana-like activity of new synthetic tetrahydrocannabinols.
Martin BR; Dewey WL; Harris LS; Beckner J
Pharmacol Biochem Behav; 1975; 3(5):849-53. PubMed ID: 1208625
[TBL] [Abstract][Full Text] [Related]
16. Morphine and delta 9-tetrahydrocannabinol: two-way cross tolerance for antinociceptive and heart-rate responses in the rat.
Hine B
Psychopharmacology (Berl); 1985; 87(1):34-8. PubMed ID: 2997827
[TBL] [Abstract][Full Text] [Related]
17. Development of tolerance and cross-tolerance to the cataleptogenic effects of delta 8-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice.
Watanabe K; Yamamoto I; Yoshimura H
Eur J Pharmacol; 1983 Oct; 94(3-4):349-51. PubMed ID: 6317407
[TBL] [Abstract][Full Text] [Related]
18. Facilitory effect of delta 9-tetrahydrocannabinol on hypothalamically induced feeding.
Trojniar W; Wise RA
Psychopharmacology (Berl); 1991; 103(2):172-6. PubMed ID: 1851306
[TBL] [Abstract][Full Text] [Related]
19. Involvement of central alpha-adrenoceptors in the hypotensive and bradycardic effects of (--)-delta 9-trans-tetrahydrocannabinol.
Lokhandwala MF; Pariani HK; Buckley JP; Jandhyala BS
Eur J Pharmacol; 1977 Mar; 42(2):107-12. PubMed ID: 191263
[TBL] [Abstract][Full Text] [Related]
20. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
